MICROSATELLITE INSTABILITY-HIGH SOLID MALIGNANT TUMOR
Clinical trials for MICROSATELLITE INSTABILITY-HIGH SOLID MALIGNANT TUMOR explained in plain language.
Never miss a new study
Get alerted when new MICROSATELLITE INSTABILITY-HIGH SOLID MALIGNANT TUMOR trials appear
Sign up with your email to follow new studies for MICROSATELLITE INSTABILITY-HIGH SOLID MALIGNANT TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for Hard-to-Treat brain cancers
Disease control Recruiting nowThis study tests an experimental oral drug called NEO212 in adults with certain brain tumors (astrocytoma, glioblastoma) or cancers that have spread to the brain. The goal is to find the safest dose and see if it can slow tumor growth. About 134 participants will receive NEO212 a…
Matched conditions: MICROSATELLITE INSTABILITY-HIGH SOLID MALIGNANT TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Neonc Technologies, Inc. • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Can diabetes drugs boost cancer immunotherapy? new trial aims to find out.
Disease control Recruiting nowThis study is for people with advanced solid tumors like melanoma, lung cancer, or liver cancer. It tests whether adding metformin or rosiglitazone (drugs that change how cells use energy) to standard immunotherapy (anti-PD-1) can improve treatment response. Participants will hav…
Matched conditions: MICROSATELLITE INSTABILITY-HIGH SOLID MALIGNANT TUMOR
Phase: PHASE2 • Sponsor: Dan Zandberg • Aim: Disease control
Last updated May 15, 2026 11:57 UTC